Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study.

Kang, Yu Min; Lim, Jaegyun; Choe, Kang-Won; Lee, Ki-Deok; Jo, Dong Ho; Kim, Moon Jung; Kim, Jong Min; Kim, Kwang Nam.

Afiliação

Kang YM; Division of Infectious Diseases, Department of Internal Medicine, Myongji Hospital, Goyang, Korea.
Lim J; Department of Laboratory Medicine, Myongji Hospital, Goyang, Korea.
Choe KW; Division of Infectious Diseases, Department of Internal Medicine, Myongji Hospital, Goyang, Korea.
Lee KD; Division of Infectious Diseases, Department of Internal Medicine, Myongji Hospital, Goyang, Korea.
Jo DH; Division of Infectious Diseases, Department of Internal Medicine, Myongji Hospital, Goyang, Korea.
Kim MJ; Department of Laboratory Medicine, Myongji Hospital, Goyang, Korea.
Kim JM; Department of Pediatrics, Myongji Hospital, Goyang, Korea.
Kim KN; Department of Pediatrics, Myongji Hospital, Goyang, Korea.

Clin Exp Vaccine Res ; 10(3): 282-289, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34703812